We show here that combining ICB using antibodies blocking TIM-1, an immune checkpoint expressed on immunosuppressive and tumor-promoting B-cells (22), significantly improves survival in ICB-resistant murine HCC. The gene discussed is HAVCR1; the disease is hepatocellular carcinoma.